Healthcare -
Biotechnology - NASDAQ - US
$ 7.29
-14.1 %
$ 755 M
Market Cap
-1.38
P/E
NTLA - REVENUE
Revenue NTLA - Intellia Therapeutics, Inc.
57.9 M
LAST VALUE
5.38%
2 YEAR CAGR
6.07%
5 YEAR CAGR
0.00%
10 YEAR CAGR